Skip to content

Tubeless Versus Standard Upper Pole Percutaneous Nephrolithotomy

Comparison of Complications Between Patients Undergoing Standard Percutaneous Nephrolithotomy With Nephrostomy Tube Placement and Tubeless Percutaneous Nephrolithotomy With Double J Stent Only Placement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02036398
Enrollment
75
Registered
2014-01-15
Start date
2013-01-31
Completion date
2017-04-07
Last updated
2018-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion

Keywords

Percutaneous Nephrolithotomy (PCNL), Nephrostomy, Double J stent, PleuraL Effusion

Brief summary

Comparison of complications between standard upper pole percutaneous nephrolithotomy (PCNL) with nephrostomy placement and double J stent and PCNL with double J placement only without nephrostomy.

Detailed description

Measurement of complications in and comparison between two groups of patients undergoing upper pole PCNL. First group consists of patients left with nephrostomy and double J stent and the second group includes patients left with double J stent only without nephrostomy.

Interventions

DEVICEDouble J stent without nephrostomy

Double J stent only left at the end of the procedure without placement of a nephrostomy tube

DEVICEnephrostomy tube and double J stent

Double J stent and nephrostomy tube left at end of procedure

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing upper pole percutaneous nephrolithotomy older than 18 years of age and willing to participate

Exclusion criteria

* Patients younger than 18 years of age * Patients unwilling to participate in the study * Patients that nephrostomy tube placement was a prerequisite at the end of the procedure

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with pleural effusion30 daysAssessment and comparison of pleural effusion incidence between patients in both groups

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026